Johnson & Johnson and Takeda Pharmaceuticals win bid to establish biotech incubator in Israel.
BioBoost, a consortium of US-based healthcare company Johnson & Johnson, Japan-based pharmaceuticals company Takeda Pharmaceuticals and venture capital firm OrbiMed, has won its bid for a license to run a biotech incubator which is being set up under Israel’s Technological Incubators Program. Big Boost was running against a rival consortium comprised of UK-based pharmaceutical company AstraZeneca and Minrav Holdings.
The license lasts for eight years, and the consortium will receive $1.9m financing from Israel’s Chief Scientist over three years. The…
